標(biāo)題: Titlebook: New Antimicrobials: For the Present and the Future; I.W. Fong Book 2023 The Editor(s) (if applicable) and The Author(s), under exclusive l [打印本頁] 作者: HEMI 時(shí)間: 2025-3-21 19:45
書目名稱New Antimicrobials: For the Present and the Future影響因子(影響力)
書目名稱New Antimicrobials: For the Present and the Future影響因子(影響力)學(xué)科排名
書目名稱New Antimicrobials: For the Present and the Future網(wǎng)絡(luò)公開度
書目名稱New Antimicrobials: For the Present and the Future網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱New Antimicrobials: For the Present and the Future被引頻次
書目名稱New Antimicrobials: For the Present and the Future被引頻次學(xué)科排名
書目名稱New Antimicrobials: For the Present and the Future年度引用
書目名稱New Antimicrobials: For the Present and the Future年度引用學(xué)科排名
書目名稱New Antimicrobials: For the Present and the Future讀者反饋
書目名稱New Antimicrobials: For the Present and the Future讀者反饋學(xué)科排名
作者: CUR 時(shí)間: 2025-3-22 00:17 作者: 天賦 時(shí)間: 2025-3-22 02:05
I. W. Fonger Querschnittsschwerpunkte ersetzt. .? Es wird vorausgesetzt, dass alle Einwirkungen zeitlich unver?nderlich sind, so dass keine dynamischen Effekte auftreten. .? Bei der Formulierung des Gleichgewichts werden die Tragwerksverformungen als vernachl?ssigbar klein angenommen, d. h. es wird nach der T作者: 獨(dú)行者 時(shí)間: 2025-3-22 06:32
Antimicrobial Resistance: A Crisis in the Making,sistant .) and malaria (artemisinin-resistant .), certain viral infections (cytomegalovirus and human immunodeficiency virus), and specific fungal opportunistic pathogens (. and . sp.)..It is estimated that 700,000 deaths occur yearly in the world from AMR infections and projected to escalate to ten作者: creatine-kinase 時(shí)間: 2025-3-22 12:19
New Glycopeptides: Telavancin, Dalbavancin, and Oritavancines to meet the unmet needs. These new agents, telavancin, dalbavancin, and oritavancin, are more potent and have superior pharmacokinetic profile than the first-generation glycopeptides (vancomycin and teicoplanin). This chapter discusses these new semisynthetic agents’ in vitro activity, pharmacolo作者: 虛度 時(shí)間: 2025-3-22 16:25
New Tetracyclines: Eravacycline and Omadacyclinea-abdominal infections and omadacycline for community-acquired pneumonia and acute bacterial skin and soft tissue infections. This chapter reviews their chemical structure, pharmacokinetic and pharmacodynamics parameters, microbial activity, ease of resistance, clinical efficacy, adverse effects, an作者: 配置 時(shí)間: 2025-3-22 17:25 作者: 講個(gè)故事逗他 時(shí)間: 2025-3-22 23:15
New Antiviral Agent for Influenza: Baloxaviroral antiviral, baloxavir, was approved in the United States for influenza infection. This chapter reviews the chemistry, antiviral activity, pharmacokinetics, efficacy, and side effects of baloxavir.作者: 惡意 時(shí)間: 2025-3-23 04:30
Book 2023for future use. Discussion of each drug will include its chemical nature, pharmacology/pharmacokinetics, antimicrobial spectrum, dosage, adverse reactions, drug interactions, microbial resistance, indications, clinical efficacy compared to older agents, and lists of similar agents with cost comparis作者: dandruff 時(shí)間: 2025-3-23 09:28 作者: NATTY 時(shí)間: 2025-3-23 10:34
Emerging Infectious Diseases of the 21st Centuryhttp://image.papertrans.cn/n/image/664778.jpg作者: QUAIL 時(shí)間: 2025-3-23 17:14 作者: 錫箔紙 時(shí)間: 2025-3-23 18:40 作者: 蒙太奇 時(shí)間: 2025-3-23 22:21 作者: 碎片 時(shí)間: 2025-3-24 04:45
New Antimicrobials: For the Present and the Future978-3-031-26078-0Series ISSN 1573-4684 Series E-ISSN 2627-5872 作者: 巨碩 時(shí)間: 2025-3-24 07:16 作者: 用肘 時(shí)間: 2025-3-24 12:46
I. W. Fongegesteif oder mittels geeigneter Mechanismen, z. B. durch Gelenke, miteinander verbunden. Der Begriff Stab wurde in Abschnitt 1.1.2.3 definiert. Die Berechnung r?umlicher Stabwerke ist kompliziert und aufwendig. Deshalb zerlegt man das reale Tragwerk nach M?glichkeit gedanklich in ebene Teilstruktur作者: Daily-Value 時(shí)間: 2025-3-24 18:23 作者: 津貼 時(shí)間: 2025-3-24 20:22 作者: engrave 時(shí)間: 2025-3-25 02:01 作者: CRANK 時(shí)間: 2025-3-25 06:07 作者: Predigest 時(shí)間: 2025-3-25 09:11 作者: Temporal-Lobe 時(shí)間: 2025-3-25 13:19
New Oxazolidinone: Tedizolids approved for clinical use in the United States in 2000 and tedizolid was approved in 2014. Although resistance is rare to linezolid among gram-positive bacteria, tedizolid has greater potency, less frequent dosing, reduced hematological side effects, and less concern for monoamine oxidase inhibiti作者: 催眠藥 時(shí)間: 2025-3-25 18:00
New Tetracyclines: Eravacycline and Omadacyclinereased resistance, even to the semisynthetic second-generation compounds, doxycycline and minocycline, introduced in the 1960s–1970s. In the early 2000s, modification of the structure of minocycline led to the development of the third-generation, broader-spectrum tigecycline. Although effective agai作者: blight 時(shí)間: 2025-3-25 21:05 作者: 幾何學(xué)家 時(shí)間: 2025-3-26 00:23 作者: ineptitude 時(shí)間: 2025-3-26 07:05
New Systemic Antifungal: Isavuconazolene marrow transplantations, and autoimmune diseases. The need for new antifungal agents has arisen with the emergence of azole-resistant . species and multiresistant ., besides the shortcomings of existent agents. The azole class of agents is associated with potentially dangerous drug-drug interacti作者: Creditee 時(shí)間: 2025-3-26 10:37 作者: 的是兄弟 時(shí)間: 2025-3-26 13:53
New Antiretroviral Agents for HIV Infectionerapeutics. Once a death sentence, now HIV can be controlled with a single pill daily that result in lifespan almost the same as normal people. The advent of this triumph started with the development of potent combination therapy delivered in a single tablet or capsule, the first triple combination 作者: 斷言 時(shí)間: 2025-3-26 17:21 作者: 夜晚 時(shí)間: 2025-3-27 00:02 作者: Constituent 時(shí)間: 2025-3-27 02:54 作者: Confound 時(shí)間: 2025-3-27 07:58 作者: 制造 時(shí)間: 2025-3-27 12:57 作者: FLIC 時(shí)間: 2025-3-27 16:58
New Antiviral Agents for Cytomegalovirus Diseases-resistant strains. Two new drugs to combat CMV infections have been recently approved: letermovir tablets and injections for prophylactic treatment of HSCT and maribavir for refractory or drug-resistant CMV infections. Their chemistry, antiviral activity, pharmacokinetics, efficacy, and safety are reviewed in this chapter.作者: 消滅 時(shí)間: 2025-3-27 20:31
Direct Antiviral Agents for Hepatitis C now five fixed combinations and eight DAA for treatment of chronic hepatitis C, the choice and duration depending on the genotype, presence or absence of cirrhosis, previous treatment, and renal impairment. The various combinations will be reviewed including mechanisms of action, efficacy, adverse effects, and cost.作者: 貪婪的人 時(shí)間: 2025-3-28 00:13
Book 2023tance is a major threat to global population health, with government reports projecting it could result in over 10 million deaths in the next 35 years. Development of new agents to combat this threat is one of the WHO‘s top priorities, but in 2017, it conceded that the current drug development pipel作者: Irritate 時(shí)間: 2025-3-28 04:48
A New Fluoroquinolone: Delafloxacine for intravenous and oral administration and is approved in several countries for skin and soft tissue infections. In this chapter the antimicrobial activity, pharmacokinetic/pharmacodynamics properties, clinical efficacy, and side effects are reviewed.作者: 征兵 時(shí)間: 2025-3-28 08:19 作者: 施加 時(shí)間: 2025-3-28 12:11
1573-4684 re, antimicrobial spectrum, dosage, efficacy, and more for eThis is a timely and essential companion to the recently published .Antimicrobial Resistance in the 21st Century, Second Edition. .Antimicrobial resistance is a major threat to global population health, with government reports projecting it作者: 侵略主義 時(shí)間: 2025-3-28 17:55 作者: 上下倒置 時(shí)間: 2025-3-28 18:45
Pleuromutilin: A New Class of Antibiotic: Lefamulin typical and atypical bacteria that are causes of community-acquired pneumonia and is available in parenteral and oral formulations. The pharmacokinetics, microbial activity, clinical efficacy, and safety profile in phase 3 trials, and place in therapy are reviewed in this chapter.作者: Cytology 時(shí)間: 2025-3-29 00:46 作者: 虛構(gòu)的東西 時(shí)間: 2025-3-29 05:21 作者: Implicit 時(shí)間: 2025-3-29 09:04 作者: 偽造 時(shí)間: 2025-3-29 14:09
Reaching Approximate Byzantine Consensus with Multi-hop Communications paper. Our necessary and sufficient condition generalizes the tight condition identified in prior work for .. For ., where . is the length of a longest cycle-free path in the given network, our condition is equivalent to the necessary and sufficient conditions for exact consensus in undirected and directed networks both.作者: FEIGN 時(shí)間: 2025-3-29 16:10 作者: 遭遇 時(shí)間: 2025-3-29 22:49 作者: intangibility 時(shí)間: 2025-3-30 00:18
JMLAutoTest: A Novel Automated Testing Framework Based on JML and JUnitcan avoid most meaningless cases by running the test in a double-phase way which saves much time of exploring meaningless cases in the test. This method can be adopted in the testing not only for Java programs, but also for programs written with other languages. Finally, JMLAutoTest executes the met作者: 古代 時(shí)間: 2025-3-30 06:12
n them as much as humans and their technologies. The book enables readers to gain extensive insights into the aspirations and practices of fishing in North Korea and its neighbours, the navigation of difficult 978-981-15-0044-2978-981-15-0042-8作者: 大酒杯 時(shí)間: 2025-3-30 10:35
sible at all to accomplish a computer vision task. Performance was a secondary issue..Now, however, a major interesting question is how to quickly design machine vision systems which work efficiently and which meet requirements. To do this requires an engineering basis which describes precisely what作者: 東西 時(shí)間: 2025-3-30 14:16 作者: aptitude 時(shí)間: 2025-3-30 17:43
